Machine learning to predict tamoxifen adherence among U.S. commercially insured breast cancer patients.

276Background: Adherence to tamoxifen among women diagnosed with hormone receptor positive metastatic breast cancer (mBC) can improve survival and minimize recurrence. Screening for non-adherence a...